BRISTOLMYERSDRNBRISTOLMYERSDRNBRISTOLMYERSDRN

BRISTOLMYERSDRN

No trades
See on Supercharts

Key facts today


Bristol Myers Squibb (BMY) has a 5.4% dividend yield, despite a 20% stock price drop this year due to worries about its drug pipeline and a lowered 2025 earnings outlook.
Analyze the impactAnalyze the impact
Market capitalization
‪501.23 B‬BRL
0.01BRL
‪−48.24 B‬BRL
‪260.38 B‬BRL
Beta (1Y)
−0.71

About Bristol-Myers Squibb Company


CEO
Christopher S. Boerner
Website
Headquarters
Princeton
Founded
1933
ISIN
BRBMYBBDR000
FIGI
BBG0025NPDT2
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Check out other big names from the same industry as BMYB34.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
C
BMY4036425
Celgene Corporation 5.25% 15-AUG-2043
Yield to maturity
7.52%
Maturity date
Aug 15, 2043
US110122DS4
BRIST.MYERS 20/50
Yield to maturity
7.26%
Maturity date
Nov 13, 2050
C
BMY4124214
Celgene Corporation 4.625% 15-MAY-2044
Yield to maturity
6.81%
Maturity date
May 15, 2044
US110122DX3
BRIST.MYERS 22/62
Yield to maturity
6.61%
Maturity date
Mar 15, 2062
C
BMY3685700
Celgene Corporation 5.7% 15-OCT-2040
Yield to maturity
6.59%
Maturity date
Oct 15, 2040
C
BMY4560589
Celgene Corporation 4.35% 15-NOV-2047
Yield to maturity
6.55%
Maturity date
Nov 15, 2047
US110122DW5
BRIST.MYERS 22/52
Yield to maturity
6.53%
Maturity date
Mar 15, 2052
C
BMY4275603
Celgene Corporation 5.0% 15-AUG-2045
Yield to maturity
6.49%
Maturity date
Aug 15, 2045
US110122DR6
BRIST.MYERS 20/40
Yield to maturity
6.43%
Maturity date
Nov 13, 2040
BMY5009254
Bristol-Myers Squibb Company 4.25% 26-OCT-2049
Yield to maturity
6.22%
Maturity date
Oct 26, 2049
C
BMY4597874
Celgene Corporation 4.55% 20-FEB-2048
Yield to maturity
6.19%
Maturity date
Feb 20, 2048

See all BMYB34 bonds